Elanco Animal Health (ELAN) Change in Acquisitions & Divestments (2020)
Elanco Animal Health (ELAN) reported Change in Acquisitions & Divestments of -$300000.0 for Q4 2020, down 103.75% sequentially from $8.0 million in Q2 2020.
Elanco Animal Health (ELAN) Change in Acquisitions & Divestments (2020) Analysis & Trends
Elanco Animal Health (ELAN) has 1 years of Change in Acquisitions & Divestments data on file, last reported at -$300000.0 in Q4 2020.
- For the quarter ending Q4 2020, Change in Acquisitions & Divestments changed N/A year-over-year to -$300000.0; the trailing twelve-month figure through Sep 2021 stood at -$300000.0 (down 100.91% YoY), and the FY2020 full-year result was $32.7 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments retreated to -$300000.0 in Q4 2020, from $8.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $25.0 million in Q1 2020 to a low of -$300000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -300,000.00 |
| Dec 31, 2020 | -300,000.00 |
| Jun 30, 2020 | 8.00 Mn |
| Jun 30, 2020 | 8.00 Mn |
| Mar 31, 2020 | 25.00 Mn |
| Mar 31, 2020 | 25.00 Mn |